500 Boylston Street, Boston, MA 02116 617-419-4700
Return to Results
To collect information and evaluate the performance of the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface when used in the Superficial Femoral Artery.
Time: Baseline Visit, 1 month visit/telephone call, 6 month visit, and 12 month visit.
Inclusion: Subjects at least 21 years of age with lifestyle-limiting claudication, rest pain, or tissue loss affecting a lower extremity. Subjects with an ankle brachial index of 0.9 or less with a life expectancy of at least 12 months.
Sponsor: W.L. Gore & Associates
Phase: Phase 4
Trial ID: SFA Disease
Not Accepting Healthy Volunteers